Perspectives on Business Management, |
Home | About PBME | PBMEIT Conference | Scope | Indexing | Editorial Team | Call for Chapters | Authors Guidelines | Global Research Perspectives |
PBME Volume IV ISBN: 978-81-951151-2-9
Author(s): SONIA PURANG & Dr. P.S. RAYCHAUDHURI
Abstract
The COVID-19 illness, as a global pandemic is an emerging and rapidly evolving situation that has collapsed the health departments of the world. It has also shattered the economy of the different nations in the world. Body immunity is the key factor highlighted in many types of research to prevent COVID-19 disease. People with co-morbidities like diabetes, hypertension, cardiovascular disease, and respiratory issues are at higher risk of having COVID-19. The studies have revealed that people with pre-existing conditions face a higher mortality rate as compared to people affected with no co-morbidities. It also depends on age as the general immunity reduces as you get older. This study talks about the co-morbidity impact on COVID-19, co-morbidity chronic problems, and their treatment for proper healthcare management. It also explores the Post- COVID-19 symptoms and the health management implications involved in long -term effects. The measures to improve the public health and recovery of patients post Covid-19 illness has great significance and important implications for society in terms of livelihood and work productivity.
Keywords: co-morbidity, post-covid-19, drug re-purpose, market demand, promotion
JEL Classification: I10, I18, M30
Download Full Paper (PDF)
© 2020-2024 Perspectives on Business Management & Economics (PBME)